Fenwick Helps Cancer Biotech Freenome Raise $270M
Law360 (August 26, 2020, 5:04 PM EDT) — Biotechnology company Freenome said Wednesday it raised $270 million in a financing round steered by Fenwick & West LLP that the company will use to advance its cancer detection technology.
California-headquartered Freenome said that including the latest Series C round, it has raised more than $500 million. Proceeds from the latest round will go toward advancing clinical trials for Freenome’s blood test for colorectal cancer screening and precancerous lesion detection, the announcement said.
The company in May launched Preempt CRC, a U.S. Food and Drug Administration registrational study, in an effort to advance the blood test toward FDA approval, the announcement…